[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Meningococcal Vaccines Market Research Report 2022(Status and Outlook)

June 2022 | 104 pages | ID: G5CA1C52DD03EN
Bosson Research

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

The Global Meningococcal Vaccines Market Size was estimated at USD 250.78 million in 2021 and is projected to reach USD 340.00 million by 2028, exhibiting a CAGR of 4.44% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Meningococcal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Vaccines market in any manner.

Global Meningococcal Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company
  • GlaxoSmithKline
  • JN-International Medical
  • Novartis International
  • Sanofi
  • Pfizer
  • Baxter International
  • ...
Market Segmentation (by Type)
  • Menactra
  • Menomune
Market Segmentation (by Application)
  • Pneumonia
  • Meningitis
  • Bacteremia
  • Others (Arthritis, Conjunctivitis, Urethritis)
Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Meningococcal Vaccines Market
  • Overview of the regional outlook of the Meningococcal Vaccines Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Meningococcal Vaccines
1.2 Key Market Segments
  1.2.1 Meningococcal Vaccines Segment by Type
  1.2.2 Meningococcal Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MENINGOCOCCAL VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Meningococcal Vaccines Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Meningococcal Vaccines Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MENINGOCOCCAL VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Global Meningococcal Vaccines Sales by Manufacturers (2017-2022)
3.2 Global Meningococcal Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.3 Meningococcal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Vaccines Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Meningococcal Vaccines Sales Sites, Area Served, Product Type
3.6 Meningococcal Vaccines Market Competitive Situation and Trends
  3.6.1 Meningococcal Vaccines Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Meningococcal Vaccines Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 MENINGOCOCCAL VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Meningococcal Vaccines Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 MENINGOCOCCAL VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccines Sales Market Share by Type (2017-2022)
6.3 Global Meningococcal Vaccines Market Size Market Share by Type (2017-2022)
6.4 Global Meningococcal Vaccines Price by Type (2017-2022)

7 MENINGOCOCCAL VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccines Market Sales by Application (2017-2022)
7.3 Global Meningococcal Vaccines Market Size (M USD) by Application (2017-2022)
7.4 Global Meningococcal Vaccines Sales Growth Rate by Application (2017-2022)

8 MENINGOCOCCAL VACCINES MARKET SEGMENTATION BY REGION

8.1 Global Meningococcal Vaccines Sales by Region
  8.1.1 Global Meningococcal Vaccines Sales by Region
  8.1.2 Global Meningococcal Vaccines Sales Market Share by Region
8.2 North America
  8.2.1 North America Meningococcal Vaccines Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Meningococcal Vaccines Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Meningococcal Vaccines Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Meningococcal Vaccines Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Meningococcal Vaccines Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 GlaxoSmithKline
  9.1.1 GlaxoSmithKline Meningococcal Vaccines Basic Information
  9.1.2 GlaxoSmithKline Meningococcal Vaccines Product Overview
  9.1.3 GlaxoSmithKline Meningococcal Vaccines Product Market Performance
  9.1.4 GlaxoSmithKline Business Overview
  9.1.5 GlaxoSmithKline Meningococcal Vaccines SWOT Analysis
  9.1.6 GlaxoSmithKline Recent Developments
9.2 JN-International Medical
  9.2.1 JN-International Medical Meningococcal Vaccines Basic Information
  9.2.2 JN-International Medical Meningococcal Vaccines Product Overview
  9.2.3 JN-International Medical Meningococcal Vaccines Product Market Performance
  9.2.4 JN-International Medical Business Overview
  9.2.5 JN-International Medical Meningococcal Vaccines SWOT Analysis
  9.2.6 JN-International Medical Recent Developments
9.3 Novartis International
  9.3.1 Novartis International Meningococcal Vaccines Basic Information
  9.3.2 Novartis International Meningococcal Vaccines Product Overview
  9.3.3 Novartis International Meningococcal Vaccines Product Market Performance
  9.3.4 Novartis International Business Overview
  9.3.5 Novartis International Meningococcal Vaccines SWOT Analysis
  9.3.6 Novartis International Recent Developments
9.4 Sanofi
  9.4.1 Sanofi Meningococcal Vaccines Basic Information
  9.4.2 Sanofi Meningococcal Vaccines Product Overview
  9.4.3 Sanofi Meningococcal Vaccines Product Market Performance
  9.4.4 Sanofi Business Overview
  9.4.5 Sanofi Meningococcal Vaccines SWOT Analysis
  9.4.6 Sanofi Recent Developments
9.5 Pfizer
  9.5.1 Pfizer Meningococcal Vaccines Basic Information
  9.5.2 Pfizer Meningococcal Vaccines Product Overview
  9.5.3 Pfizer Meningococcal Vaccines Product Market Performance
  9.5.4 Pfizer Business Overview
  9.5.5 Pfizer Meningococcal Vaccines SWOT Analysis
  9.5.6 Pfizer Recent Developments
9.6 Baxter International
  9.6.1 Baxter International Meningococcal Vaccines Basic Information
  9.6.2 Baxter International Meningococcal Vaccines Product Overview
  9.6.3 Baxter International Meningococcal Vaccines Product Market Performance
  9.6.4 Baxter International Business Overview
  9.6.5 Baxter International Recent Developments
9.7 ...
  9.7.1 ... Meningococcal Vaccines Basic Information
  9.7.2 ... Meningococcal Vaccines Product Overview
  9.7.3 ... Meningococcal Vaccines Product Market Performance
  9.7.4 ... Business Overview
  9.7.5 ... Recent Developments

10 MENINGOCOCCAL VACCINES MARKET FORECAST BY REGION

10.1 Global Meningococcal Vaccines Market Size Forecast
10.2 Global Meningococcal Vaccines Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Meningococcal Vaccines Market Size Forecast by Country
  10.2.3 Asia Pacific Meningococcal Vaccines Market Size Forecast by Region
  10.2.4 South America Meningococcal Vaccines Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Vaccines by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Meningococcal Vaccines Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Meningococcal Vaccines by Type (2022-2028)
  11.1.2 Global Meningococcal Vaccines Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Meningococcal Vaccines by Type (2022-2028)
11.2 Global Meningococcal Vaccines Market Forecast by Application (2022-2028)
  11.2.1 Global Meningococcal Vaccines Sales (K Units) Forecast by Application
  11.2.2 Global Meningococcal Vaccines Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Vaccines Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Meningococcal Vaccines Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Meningococcal Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Meningococcal Vaccines Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Meningococcal Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccines as of 2021)
Table 10. Global Market Meningococcal Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Meningococcal Vaccines Sales Sites and Area Served
Table 12. Manufacturers Meningococcal Vaccines Product Type
Table 13. Global Meningococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningococcal Vaccines
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Vaccines Market Challenges
Table 22. Market Restraints
Table 23. Global Meningococcal Vaccines Sales by Type (K Units)
Table 24. Global Meningococcal Vaccines Market Size by Type (M USD)
Table 25. Global Meningococcal Vaccines Sales (K Units) by Type (2017-2022)
Table 26. Global Meningococcal Vaccines Sales Market Share by Type (2017-2022)
Table 27. Global Meningococcal Vaccines Market Size (M USD) by Type (2017-2022)
Table 28. Global Meningococcal Vaccines Market Size Share by Type (2017-2022)
Table 29. Global Meningococcal Vaccines Price (USD/Unit) by Type (2017-2022)
Table 30. Global Meningococcal Vaccines Sales (K Units) by Application
Table 31. Global Meningococcal Vaccines Market Size by Application
Table 32. Global Meningococcal Vaccines Sales by Application (2017-2022) & (K Units)
Table 33. Global Meningococcal Vaccines Sales Market Share by Application (2017-2022)
Table 34. Global Meningococcal Vaccines Sales by Application (2017-2022) & (M USD)
Table 35. Global Meningococcal Vaccines Market Share by Application (2017-2022)
Table 36. Global Meningococcal Vaccines Sales Growth Rate by Application (2017-2022)
Table 37. Global Meningococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 38. Global Meningococcal Vaccines Sales Market Share by Region (2017-2022)
Table 39. North America Meningococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 40. Europe Meningococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Meningococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 42. South America Meningococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Meningococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 44. GlaxoSmithKline Meningococcal Vaccines Basic Information
Table 45. GlaxoSmithKline Meningococcal Vaccines Product Overview
Table 46. GlaxoSmithKline Meningococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Meningococcal Vaccines SWOT Analysis
Table 49. GlaxoSmithKline Recent Developments
Table 50. JN-International Medical Meningococcal Vaccines Basic Information
Table 51. JN-International Medical Meningococcal Vaccines Product Overview
Table 52. JN-International Medical Meningococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. JN-International Medical Business Overview
Table 54. JN-International Medical Meningococcal Vaccines SWOT Analysis
Table 55. JN-International Medical Recent Developments
Table 56. Novartis International Meningococcal Vaccines Basic Information
Table 57. Novartis International Meningococcal Vaccines Product Overview
Table 58. Novartis International Meningococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Novartis International Business Overview
Table 60. Novartis International Meningococcal Vaccines SWOT Analysis
Table 61. Novartis International Recent Developments
Table 62. Sanofi Meningococcal Vaccines Basic Information
Table 63. Sanofi Meningococcal Vaccines Product Overview
Table 64. Sanofi Meningococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Sanofi Business Overview
Table 66. Sanofi Meningococcal Vaccines SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Pfizer Meningococcal Vaccines Basic Information
Table 69. Pfizer Meningococcal Vaccines Product Overview
Table 70. Pfizer Meningococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Pfizer Business Overview
Table 72. Pfizer Meningococcal Vaccines SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Baxter International Meningococcal Vaccines Basic Information
Table 75. Baxter International Meningococcal Vaccines Product Overview
Table 76. Baxter International Meningococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Baxter International Business Overview
Table 78. Baxter International Recent Developments
Table 79. ... Meningococcal Vaccines Basic Information
Table 80. ... Meningococcal Vaccines Product Overview
Table 81. ... Meningococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. ... Business Overview
Table 83. ... Recent Developments
Table 84. Global Meningococcal Vaccines Sales Forecast by Region (K Units)
Table 85. Global Meningococcal Vaccines Market Size Forecast by Region (M USD)
Table 86. North America Meningococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 87. North America Meningococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 88. Europe Meningococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 89. Europe Meningococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 90. Asia Pacific Meningococcal Vaccines Sales Forecast by Region (2022-2028) & (K Units)
Table 91. Asia Pacific Meningococcal Vaccines Market Size Forecast by Region (2022-2028) & (M USD)
Table 92. South America Meningococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 93. South America Meningococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 94. Middle East and Africa Meningococcal Vaccines Consumption Forecast by Country (2022-2028) & (Units)
Table 95. Middle East and Africa Meningococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 96. Global Meningococcal Vaccines Sales Forecast by Type (2022-2028) & (K Units)
Table 97. Global Meningococcal Vaccines Market Size Forecast by Type (2022-2028) & (M USD)
Table 98. Global Meningococcal Vaccines Price Forecast by Type (2022-2028) & (USD/Unit)
Table 99. Global Meningococcal Vaccines Sales (K Units) Forecast by Application (2022-2028)
Table 100. Global Meningococcal Vaccines Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Meningococcal Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Vaccines Market Size (M USD), 2017-2028
Figure 5. Global Meningococcal Vaccines Market Size (M USD) (2017-2028)
Figure 6. Global Meningococcal Vaccines Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Vaccines Market Size (M USD) by Country (M USD)
Figure 11. Meningococcal Vaccines Sales Share by Manufacturers in 2020
Figure 12. Global Meningococcal Vaccines Revenue Share by Manufacturers in 2020
Figure 13. Meningococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Meningococcal Vaccines Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccines Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningococcal Vaccines Market Share by Type
Figure 18. Sales Market Share of Meningococcal Vaccines by Type (2017-2022)
Figure 19. Sales Market Share of Meningococcal Vaccines by Type in 2021
Figure 20. Market Size Share of Meningococcal Vaccines by Type (2017-2022)
Figure 21. Market Size Market Share of Meningococcal Vaccines by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningococcal Vaccines Market Share by Application
Figure 24. Global Meningococcal Vaccines Sales Market Share by Application (2017-2022)
Figure 25. Global Meningococcal Vaccines Sales Market Share by Application in 2021
Figure 26. Global Meningococcal Vaccines Market Share by Application (2017-2022)
Figure 27. Global Meningococcal Vaccines Market Share by Application in 2020
Figure 28. Global Meningococcal Vaccines Sales Growth Rate by Application (2017-2022)
Figure 29. Global Meningococcal Vaccines Sales Market Share by Region (2017-2022)
Figure 30. North America Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Meningococcal Vaccines Sales Market Share by Country in 2020
Figure 32. U.S. Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Meningococcal Vaccines Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Meningococcal Vaccines Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Meningococcal Vaccines Sales Market Share by Country in 2020
Figure 37. Germany Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Meningococcal Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Meningococcal Vaccines Sales Market Share by Region in 2020
Figure 44. China Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Meningococcal Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Meningococcal Vaccines Sales Market Share by Country in 2020
Figure 51. Brazil Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Meningococcal Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Meningococcal Vaccines Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Meningococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Meningococcal Vaccines Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Meningococcal Vaccines Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Meningococcal Vaccines Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Meningococcal Vaccines Market Share Forecast by Type (2022-2028)
Figure 65. Global Meningococcal Vaccines Sales Forecast by Application (2022-2028)
Figure 66. Global Meningococcal Vaccines Market Share Forecast by Application (2022-2028)


More Publications